<DOC>
	<DOCNO>NCT00403078</DOCNO>
	<brief_summary>The primary objective study ass outcomes stenting distal protection treatment obstructive carotid artery disease . The device utilized Cordis PRECISE® Nitinol Stent Systems ( 5.5F 6F ) Cordis ANGIOGUARD™ XP Emboli Capture Guidewire ( ECGW ) .</brief_summary>
	<brief_title>SAPPHIRE Worldwide : Stenting Angioplasty With Protection Patients At High-Risk Endarterectomy</brief_title>
	<detailed_description>Carotid Artery Stenting</detailed_description>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>Highsurgical risk patient treat consistent IFU label The patient legally authorize representative sign write informed consent HIPAA authorization , prior procedure , use form approve Institutional Review Board Medical Ethics Committee . Patients treat per IFU Patients contraindicate per IFU Patients previously enrol study Patients require stenting instent restenosis CAS Inability refusal provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Carotid Artery Stenting ( Endovascular )</keyword>
</DOC>